2023 International Congress Archives - Page 96 of 186

Initial triggering in tibial group and subsequent slow spread of myoclonus from brain stem to eye-balls in Subacute Sclerosing Pan Encephalitis

A. Das, J. George, A. Garg, A. Srivastava (Delhi, India)
Innovating Clinical Trial Design to Accelerate Assessment of Disease-Modifying Treatments for Parkinson’s: The EJS ACT-PD Initiative

G. Mills, R. Chapman, S. Collins, R. Ellis-Doyle, C. Gonzalez-Robles, M. Zeissler, O. Bandmann, R. Barker, J. Carpenter, J. Chataway, J. Duffen, S. Gandhi, K. Mcfarthing, S. Mullin, A. Schapira, A. Schrag, C. Carroll, T. Foltynie (London, United Kingdom)
Instability after MRIg-FUS thalamotomy: why does it appear?

A. Fernandez Revuelta, C. Ribacoba Díaz, J. Porta Etessam, C. Pérez García, M. Yus, E. López Valdés, R. García-Ramos (Madrid, Spain)
Insular dopamine deficits in prodromal α-synucleinopathies

A. Galli, A. Pilotto, C. Zatti, F. Placidi, F. Izzi, E. Premi, A. Rizzardi, M. Catania, A. Lupini, L. Purin, M. Pasolini, N. Mercuri, A. Chiaravalloti, M. Fernandes, C. Calvello, B. Paghera, D. Berg, A. Padovani, C. Liguori (Brescia, Italy)
Integrated analysis of phase 3 trials of foslevodopa/foscarbidopa demonstrated that majority of reported infusion site AEs including infections were non serious, mild to moderate in severity and did not result in treatment discontinuation.

P. Odin, T. Kimber, B. Bergmans, E. Freire-Alvarez, F. Gandor, S. Isaacson, S. Dhanani, R. Hauser, M. O'Meara, A. Jeong, J. Jia, R. Gupta, L. Bergmann, M. Shah, L. Harmer, S. Talapala, J. Aldred (Lund, Sweden)
Integrated safety analysis of BIA-28-6156 phase 1 clinical trials (a novel allosteric activator of beta-glucocerebrosidase)

L. Guedes, D. Hilt, M. Fonseca, I. Peixoto, H. Gama (Coronado, Portugal)
Integrating care coordination into telemedicine services provides a better patient experience than care coordination alone: Insights from a national neurodegenerative disease telemedicine program

J. Hatcher-Martin, C. Byrne, E. Anderson (Chicago, USA)
Integrative analysis of fecal metabolomics and metagenomics for Parkinson’s disease

Y. Qian, S. Xu, X. He, Y. Lai, Y. Zhang, C. Mo, P. Ai, X. Yang, Q. Xiao (Shanghai, China)
Integrative brain states facilitate the expression of Parkinson’s tremor

MF. Dirkx, M. Shine, RC. Helmich (Nijmegen, Netherlands)
Intercultural differences in patient and clinician perceptions of MDS-UPDRS in Parkinson’s disease

V. Kaasinen, S. Luo, P. Martinez-Martin, C. Goetz, G. Stebbins (Turku, Finland)